Lotem, M., Rubin, L., Talmon, A., Ribak, Y., Lavie, D., Nechushtan, H., . . . Tal, Y. Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse events. BMJ Publishing Group.
Chicago Style (17th ed.) CitationLotem, Michal, et al. Targeted Inhibition of the IL5 Axis for Immune Checkpoint Inhibitors Eosinophilic-induced Adverse Events. BMJ Publishing Group.
MLA (9th ed.) CitationLotem, Michal, et al. Targeted Inhibition of the IL5 Axis for Immune Checkpoint Inhibitors Eosinophilic-induced Adverse Events. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.